DK173685A - Ethanolaminderivater - Google Patents
Ethanolaminderivater Download PDFInfo
- Publication number
- DK173685A DK173685A DK173685A DK173685A DK173685A DK 173685 A DK173685 A DK 173685A DK 173685 A DK173685 A DK 173685A DK 173685 A DK173685 A DK 173685A DK 173685 A DK173685 A DK 173685A
- Authority
- DK
- Denmark
- Prior art keywords
- safety
- pouring stopper
- pouring
- stopper
- adrenoreceptors
- Prior art date
Links
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
hvor 3 R er hydrogen eller C^^-alkyl,
Ra er
„b og R er
eller hvor 4 R er ligekædet eller forgrenet C2_g_alkylen; og fysiologisk acceptable salte og solvater deraf.
Forbindelserne med den almene formel I har selektiv stimulerende virkning på f$2'adrenoreceptorer °9 er i$ær nyttige ved behandling af sygdomme, der er forbundet med reversibel luftvejsobstruktion såsom astma og kronisk bronkitis.
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8409908 | 1984-04-17 | ||
| GB848409908A GB8409908D0 (en) | 1984-04-17 | 1984-04-17 | Chemical compounds |
| GB848414858A GB8414858D0 (en) | 1984-06-11 | 1984-06-11 | Chemical compounds |
| GB8414858 | 1984-06-11 | ||
| GB848415762A GB8415762D0 (en) | 1984-06-20 | 1984-06-20 | Chemical compounds |
| GB848415761A GB8415761D0 (en) | 1984-06-20 | 1984-06-20 | Chemical compounds |
| GB8415762 | 1984-06-20 | ||
| GB8415761 | 1984-06-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK173685D0 DK173685D0 (da) | 1985-04-17 |
| DK173685A true DK173685A (da) | 1985-10-18 |
Family
ID=27449545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK173685A DK173685A (da) | 1984-04-17 | 1985-04-17 | Ethanolaminderivater |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0162576B1 (da) |
| AU (1) | AU581887B2 (da) |
| DE (1) | DE3571808D1 (da) |
| DK (1) | DK173685A (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8525321D0 (en) * | 1985-10-15 | 1985-11-20 | Glaxo Group Ltd | Chemical compounds |
| GB8525484D0 (en) * | 1985-10-16 | 1985-11-20 | Glaxo Group Ltd | Chemical compounds |
| GB8525483D0 (en) * | 1985-10-16 | 1985-11-20 | Glaxo Group Ltd | Chemical compounds |
| US4937268A (en) * | 1987-03-12 | 1990-06-26 | Glaxo Group Limited | Chemical compounds |
| GB8718938D0 (en) * | 1987-08-11 | 1987-09-16 | Glaxo Group Ltd | Chemical compounds |
| JPH0228141A (ja) * | 1987-11-13 | 1990-01-30 | Glaxo Group Ltd | フェネタノールアミン誘導体 |
| ZA889405B (en) * | 1987-12-18 | 1989-12-27 | Glaxo Group Ltd | Ethanolamine derivatives |
| NZ227365A (en) * | 1987-12-18 | 1990-10-26 | Glaxo Group Ltd | Aromatic amino ethers and pharmaceutical compositions |
| ES2142771B1 (es) * | 1998-09-28 | 2001-01-01 | Vita Invest Sa | Nuevos derivados de la 6-(4-fenil-butoxi) hexilamina y procedimiento para la obtencion de salmeterol. |
| GB0103630D0 (en) | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
| ATE365720T1 (de) | 2001-03-08 | 2007-07-15 | Glaxo Group Ltd | Agonisten von beta-adrenorezeptoren |
| ATE381537T1 (de) | 2001-03-22 | 2008-01-15 | Glaxo Group Ltd | Formanilid-derivative als beta2-adrenorezeptor- agonisten |
| SI1425001T1 (sl) | 2001-09-14 | 2009-04-30 | Glaxo Group Ltd Glaxo Welcome | Fenetanolaminski derivati za zdravljenje respiratornih bolezni |
| GB0217225D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
| EP1556342B1 (en) | 2002-10-28 | 2008-03-26 | Glaxo Group Limited | Phenethanolamine derivative for the treatment of respiratory diseases |
| GB0303396D0 (en) | 2003-02-14 | 2003-03-19 | Glaxo Group Ltd | Medicinal compounds |
| GB0329182D0 (en) | 2003-12-17 | 2004-01-21 | Glaxo Group Ltd | Chemical compounds |
| TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| WO2008041914A1 (en) * | 2006-10-06 | 2008-04-10 | Astrazeneca Ab | 5-(2-AMINO-L-HYDROXYETHYL)-8-HYDROXY-2-OXOQUINOLINE DERIVATIVES AND OTHER COMPOUNDS AS β2 -ADRENERGIC AGONISTS |
| TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
| EP2303873A4 (en) | 2008-06-18 | 2012-01-04 | Astrazeneca Ab | BENZOXAZINE DERIVATIVES AS A BETA2 ADRENORE RECEPTOR AGONIST FOR THE TREATMENT OF RESPIRATORY DISEASES |
| CN104230777B (zh) * | 2013-06-19 | 2016-12-28 | 重庆润泽医药有限公司 | 一种奥拉西坦的合成方法 |
| CN106478432A (zh) * | 2016-08-29 | 2017-03-08 | 鲁南制药集团股份有限公司 | 一种昔奈酸沙美特罗的制备方法 |
| CN106397228A (zh) * | 2016-08-29 | 2017-02-15 | 鲁南制药集团股份有限公司 | 一种沙美特罗碱基的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3061205D1 (en) * | 1979-06-16 | 1983-01-05 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
| LU85856A1 (fr) * | 1984-04-17 | 1986-06-11 | Glaxo Group Ltd | Composes de phenethanolamine |
| GB8525321D0 (en) * | 1985-10-15 | 1985-11-20 | Glaxo Group Ltd | Chemical compounds |
| GB8426191D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
-
1985
- 1985-04-17 EP EP19850302708 patent/EP0162576B1/en not_active Expired
- 1985-04-17 AU AU41346/85A patent/AU581887B2/en not_active Ceased
- 1985-04-17 DK DK173685A patent/DK173685A/da active IP Right Grant
- 1985-04-17 DE DE8585302708T patent/DE3571808D1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU4134685A (en) | 1985-10-24 |
| EP0162576B1 (en) | 1989-07-26 |
| EP0162576A1 (en) | 1985-11-27 |
| AU581887B2 (en) | 1989-03-09 |
| DK173685D0 (da) | 1985-04-17 |
| DE3571808D1 (en) | 1989-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK173685A (da) | Ethanolaminderivater | |
| EP0321122A3 (en) | Water soluble camptothecin analogs | |
| MY102087A (en) | Phenethanolamine derivatives. | |
| HU912819D0 (en) | Heterocyclic derivatives, method for preparing same, and their therapeutic applications | |
| DK173785A (da) | Phenylethanolaminderivater | |
| EP0354777A3 (en) | 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives | |
| ES524532A0 (es) | Procedimiento de preparacion de los derivados de la xantina | |
| DK286982A (da) | Fremgangsmaade til fremstilling af pyrimidonderivater | |
| FR2549049B1 (fr) | Nouvelles amidines, leur procede de preparation et leur application therapeutique | |
| DK178883A (da) | 2-(2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, syreadditionssalte deraf, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater med indhold deraf | |
| EP0189272A3 (en) | New furanone derivatives, processes for preparation thereof and use thereof | |
| SE8700156L (sv) | Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav | |
| DK174782A (da) | Fremgangsmaade til fremstilling af substituerede imidazol-og imidazolinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| EP0357415A3 (en) | Use of serotonin antagonists in the treatment of cognitive disorders | |
| DK157131C (da) | Carmamyloxybenzhydrolderivater, farmaceutisk praeparat samt en fremgangsmaade til fremstilling af dette | |
| FI872980A0 (fi) | Isokinolinfoereningar, vilka har en kvaevesubstituent i 4-positionen och vilka har kardiotona fosfodiesterasfraktion iii-inhiberade egenskaper och/eller njurvasodilatoriska egenskaper. | |
| EP0373827A3 (en) | Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production | |
| DK194083A (da) | Fremgangsmaade til fremstilling af sulfonylbenzimidazoler | |
| DK490282A (da) | 1-furyl-3,4-dihydroisoquinoliner, fremgangsmaade til deres fremstilling samt deres anvendelse | |
| IT1168638B (it) | Procedimento per la determinazione dello stato di virulenza o di latenza del virus dell'herpes nei tessuti cellulari | |
| FR2569185B1 (fr) | Derives de 1-(aminophenyl)-2-amino-ethanone, procede de preparation et utilisation en therapeutique | |
| EP0337413A3 (en) | Naphthopyran derivatives and use thereof | |
| EP0278728A3 (en) | 1-(4-amino-3,5-dichlorophenyl)-2-(substituted amino)ethanol derivatives and their use in the treatment of respiratory disease | |
| ES531447A0 (es) | Procedimiento de preparar derivados de n-cicloalcoilmetil-2 oxo-3 diaril 5-6 as triacina | |
| EP0246171A3 (fr) | Compositions fongicides à base de dérivés nicotiniques, nouveaux dérivés nicotiniques et leur préparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment | ||
| B1 | Patent granted (law 1993) |


